Can IgA (Immunoglobulin A) nephropathy cause elevated liver function tests (LFTs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IgA Nephropathy Does Not Directly Cause Elevated Liver Function Tests

IgA nephropathy is a primary kidney disease characterized by mesangial IgA deposition and does not inherently cause liver dysfunction or elevated LFTs. 1 However, the relationship between IgA nephropathy and liver disease is bidirectional—liver disease can cause secondary IgA nephropathy, but IgA nephropathy itself does not damage the liver. 2

Understanding the Directional Relationship

When Liver Disease Causes IgA Nephropathy (Secondary IgA Nephropathy)

Liver cirrhosis is the leading cause of secondary IgA nephropathy, with the mechanism involving impaired hepatic clearance of circulating IgA immune complexes that subsequently deposit in renal glomeruli. 3, 2

Specific liver conditions associated with secondary IgA nephropathy include:

  • Chronic viral hepatitis (hepatitis B and C) can trigger IgA nephropathy through immune complex formation 2
  • Alcoholic cirrhosis is commonly associated with IgA nephropathy in adults 4
  • Primary hemochromatosis with resulting cirrhosis has been reported with concurrent IgA nephropathy 5
  • Wilson disease with cirrhosis can present with IgA nephropathy 4
  • Portal hypertension may play a pathogenetic role in development of IgA nephropathy in cirrhotic patients 3

When IgA Nephropathy Exists Without Liver Disease

Primary (idiopathic) IgA nephropathy is defined by dominant or co-dominant mesangial IgA deposition without underlying liver pathology. 1 In these cases, LFTs should be normal unless there is a separate, unrelated liver condition.

Clinical Scenarios Where Both May Coexist

Acute Hepatitis A with Transient IgA Nephropathy

  • Hepatitis A virus infection can cause transient IgA nephropathy that resolves spontaneously after hepatic recovery 6
  • In this scenario, elevated LFTs reflect the acute hepatitis, not the IgA nephropathy
  • The IgA nephropathy typically presents with microhematuria and proteinuria during active hepatic injury 6
  • Mesangial IgA deposits may completely disappear after HAV resolution 6

Hepatitis E with Neurological Manifestations

  • Hepatitis E can cause abnormal LFTs in patients presenting with neurological symptoms (particularly bilateral shoulder pain in middle-aged males), which is highly predictive of HEV infection 1
  • This represents a distinct clinical entity from IgA nephropathy, though HEV can cause renal manifestations including IgA nephropathy 1

Diagnostic Approach When Both Abnormalities Are Present

If a patient has both IgA nephropathy and elevated LFTs, investigate for:

  1. Chronic liver disease as the primary pathology causing secondary IgA nephropathy:

    • Screen for hepatitis B, hepatitis C, and HIV 1
    • Assess for alcoholic liver disease through detailed history 1
    • Evaluate for metabolic liver disease (hemochromatosis, Wilson disease) 5, 4
    • Check for cirrhosis and portal hypertension 3
  2. Acute viral hepatitis (particularly hepatitis A or E) causing transient IgA nephropathy 6, 1

  3. Coincidental separate liver pathology in a patient with primary IgA nephropathy 1

Key Clinical Pitfalls to Avoid

  • Do not assume IgA nephropathy is causing liver dysfunction—the kidney disease does not damage the liver 1
  • In children with IgA nephropathy and abnormal LFTs, strongly consider alpha-1-antitrypsin deficiency with associated liver disease, as glomerular changes occur in 79% of children with AAT deficiency-related liver disease 1
  • Elevated serum IgA levels alone do not indicate liver disease—they are common in IgA nephropathy regardless of liver status 4
  • Portal hypertension treatment may improve IgA nephropathy: reduction of portal pressure with propranolol and anticoagulation has led to normalization of proteinuria and hematuria in cirrhotic patients 3

Treatment Implications

When secondary IgA nephropathy occurs due to liver disease, treating the underlying hepatic condition is paramount:

  • For HBV/HCV-related cases, antiviral therapy is the mainstay of treatment with significant outcome improvement 2
  • For portal hypertension-related cases, portal pressure reduction may resolve the nephropathy 3
  • Liver transplantation can dramatically improve renal function in AAT deficiency with concurrent liver and kidney disease 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Liver Disease-Associated Glomerulopathies.

Advances in kidney disease and health, 2024

Research

Spontaneous remission of IgA nephropathy associated with resolution of hepatitis A.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.